occupational toxicology

Here at Affygility Solutions we often hear the statement, “We want it simple to use.” But, almost in the same breath, they will indicate “We want it comprehensive and want it to do this, this, and this” and “Oh, by the way does it work on iPhones, Android devices, and iPads?” As you can see, these statements presents a huge dichotomy and challenge for designers and developers that are tasked

Affygility Solutions is pleased to announce that three new OEL Fastrac monographs have been posted up to the oelfastrac.com system. These three new OEL Fastrac monographs contain both the occupational exposure limit (OEL) and the acceptable daily exposure value (ADE). The 3 new OEL Fastrac monographs include: Sulfatrim Sulindac Talc OEL Fastrac monographs provide the following benefits: Access: Unsurpassed convenience. These documents are available to pharmaceutical companies and contract manufacturers

Occupational exposure limit (OEL) for Alfuzosin HCL Affygility Solutions is pleased to announce the immediate availability of the OEL Fastrac Monograph for Alfuzosin HCL. The FDA labeled indication for alfuzosin is treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Alfuzosin is an adrenergic alpha-antagonist. Alfuzosin exhibits selectivity for alpha1-adrenergic receptors in the lower urinary tract. Blockade of these adrenoreceptors can cause smooth muscle in the bladder neck and prostate to relax,

Hydroxyzine Occupational Exposure Limit (OEL) Now Immediately Available Affygility Solutions is pleased to announce the immediate availability of the OEL Fastrac monograph for hydroxyzine. Hydroxyzine, a piperazine derivative, is a sedating antihistamine with antimuscarinic and significant sedative properties; it is also an antiemetic. Hydroxyzine is mainly used in the treatment of anxiety prior to medical procedures, and for rash with itching. The most common adverse effects reported with taking hydroxyzine compounds

Affygility Solutions is pleased to present our featured OEL Fastrac monograph for Fingolimod, Fingolimod is a human therapeutic indicated for the treatment of relapsing forms of multiple sclerosis. To find out more go to the Fingolimod OEL Fastrac page. Occupational exposure limits and acceptable daily exposure values for pharmaceuticals OEL Fastrac monographs offer the following benefits: Save time! Unsurpassed delivery with instant download. Expert preparation. Industry experts with advance degrees, professional certifications, and

Occupational exposure limit (OEL) / acceptable daily exposure value (ADE) OEL Fastrac monographs now available for caffeine and felodipine. These OEL/ADE monographs are available for instant download from the OEL Fastrac service. To learn more about these specific documents, please visit the following links: Caffeine Occupational Exposure Limit and Acceptable Daily Exposure Value Monograph Felodipine Occupational Exposure Limit and Acceptable Daily Exposure Value Monograph Occupational exposure limits and acceptable daily

Many Drugs in need of Occupational Exposure Limits (OELs) Like many occupational health professionals, I read a lot of material. Early today I was reading a 1961 Time magazine article titled, “Medicine: Too Many Drugs.” In this article, Dr. Walter Modell of Cornell University Medical College, one of America’s foremost drug experts, was quoted as saying. “No fewer than 150,000 preparations are now in use, of which 90% did not exist

Affygility Solutions is pleased to announce that it has added five more occupational exposure limit (OEL) monographs to its OEL Fastrac catalog. These new OEL monographs include the following compounds: Azelaic acid; Dimethyl fumarate; Escitalopram oxalate; Linaclotide; and Lurasidone OEL Fastrac Monographs are a convenient way to obtain occupational exposure limits and control banding assignments for active pharmaceutical ingredients. Acquiring OEL monographs has never been easier.  The OEL Fastrac service

Our catalog of occupational exposure limit monographs for pharmaceuticals continues to grow Affygility Solutions is pleased to announce that is has added eight additional active pharmaceutical ingredients (APIs) to its growing catalog of OEL Fastrac monographs. APIs that have been added in the last week include: Colchicine; Dutasteride; Esomeprazole; Fluphenazine; Indomemethacin; Liothyronine Sodium; Oxycodone; and Ranolazine. Each OEL Fastrac monograph contains important information necessary for the successful execution of your

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software